Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A

6(85.7%)

Early Phase 1

1(14.3%)

7Total

N/A(6)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06271200Not ApplicableRecruiting

Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)

Role: collaborator

NCT06262542Not ApplicableRecruiting

Efficacy and Safety of Chinese Herb Medicine-Moxibustion Therapy on Chemotherapy-Induced Leukopenia

Role: lead

NCT06294743Early Phase 1Recruiting

Posterior Tibia Nerve Neuroprolotherapy for Dysmenorrhea

Role: lead

NCT06020963Not ApplicableRecruiting

Can Acupoint Low Intensity Shockwave Therapy Improve Bladder Voiding Efficiency

Role: lead

NCT05485142Not ApplicableUnknown

The Treatment Efficacy of Prolotherapy in Bladder Voiding Dysfunction

Role: lead

NCT01532531Not ApplicableCompleted

The Effects of Collateral Meridian Therapy for Knee Osteoarthritis Pain Management

Role: lead

NCT01532466Not ApplicableCompleted

The Effect of Priming Intravenous Rocuronium on Fentanyl-Induced Coughing

Role: lead

All 7 trials loaded